Marcus Frohme

Prof. Marcus Frohme

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2021 in Critical Reviews in Biochemistry and Molecular Biology
Verified
Journal Article
Open access
JGJörn Glökler
Jörn Glökler
TLTheam Soon Lim
Theam Soon Lim
JIJeunice Ida
Jeunice Ida
MFMarcus Frohme
Marcus Frohme
The introduction of nucleic acid amplification techniques has revolutionized the field of medical diagnostics in the last decade. The advent of PCR catalyzed the increasing application of DNA, not just for molecular cloning but also for molecular based diagnostics. Since the introduction of PCR, a deeper understanding of molecular mechanisms and enzymes involved in DNA/RNA replication has spurred the development of novel methods devoid of temperature cycling. Isothermal amplification methods have since been introduced utilizing different mechanisms, enzymes, and conditions. The ease with which isothermal amplification methods have allowed nucleic acid amplification to be carried out has had a profound impact on the way molecular diagnostics are being designed after the turn of the millennium. With all the advantages isothermal amplification brings, the issues or complications surrounding each method are heterogeneous making it difficult to identify the best approach for an end-user. This review pays special attention to the various isothermal amplification methods by classifying them based on the mechanistic characteristics which include reaction formats, amplification information, promoter, strand break, and refolding mechanisms. We would also compare the efficiencies and usefulness of each method while highlighting the potential applications and detection methods involved. This review will serve as an overall outlook on the journey and development of isothermal amplification methods as a whole.

1 September 2016 in Applied & Translational Genomics
Verified
Journal Article
Open access
CEChristoph Endrullat
Christoph Endrullat
JGJörn Glökler
Jörn Glökler
PFPhilipp Franke
Philipp Franke
MFMarcus Frohme
Marcus Frohme
DNA sequencing continues to evolve quickly even after > 30 years. Many new platforms suddenly appeared and former established systems have vanished in almost the same manner. Since establishment of next-generation sequencing devices, this progress gains momentum due to the continually growing demand for higher throughput, lower costs and better quality of data. In consequence of this rapid development, standardized procedures and data formats as well as comprehensive quality management considerations are still scarce. Here, we listed and summarized current standardization efforts and quality management initiatives from companies, organizations and societies in form of published studies and ongoing projects. These comprise on the one hand quality documentation issues like technical notes, accreditation checklists and guidelines for validation of sequencing workflows. On the other hand, general standard proposals and quality metrics are developed and applied to the sequencing workflow steps with the main focus on upstream processes. Finally, certain standard developments for downstream pipeline data handling, processing and storage are discussed in brief. These standardization approaches represent a first basis for continuing work in order to prospectively implement next-generation sequencing in important areas such as clinical diagnostics, where reliable results and fast processing is crucial. Additionally, these efforts will exert a decisive influence on traceability and reproducibility of sequence data.

30 November 2011 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
KSKatja Schulze
Katja Schulze
DLDiana A López
Diana A López
UTUlrich M Tillich
Ulrich M Tillich
MFMarcus Frohme
Marcus Frohme
Currently established methods to identify viable and non-viable cells of cyanobacteria are either time-consuming (eg. plating) or preparation-intensive (eg. fluorescent staining). In this paper we present a new and fast viability assay for unicellular cyanobacteria, which uses red chlorophyll fluorescence and an unspecific green autofluorescence for the differentiation of viable and non-viable cells without the need of sample preparation.

29 June 2019 in Fullerenes, Nanotubes and Carbon Nanostructures
Verified
Journal Article
Closed access
SPSvitlana Prylutska
Svitlana Prylutska
AGAnna Grebinyk
Anna Grebinyk
OLOksana V. Lynchak
Oksana V. Lynchak
IBIryna V. Byelinska
Iryna V. Byelinska
VCVsevolod Cherepanov
Vsevolod Cherepanov
MFMarcus Frohme
Marcus Frohme
Toxicity of the C60 fullerene aqueous colloid solution in vitro and in vivo experiments was studied. C60 fullerene in the concentration range of 3.6-144 µg/mL demonstrated low toxicity against human embryonic kidney (HEK293) cells with 383.4 μg/mL IC50 value. The acute toxicity of C60 fullerene in a dose progression (75, 150, 300, 600, 1200 and 1800 mg/kg) was investigated at 14th day after single intraperitoneal (i.p.) administration into mice. No toxic effect of С60 fullerene in the dose range of 75-150 mg/kg was observed; the calculated LD50 value was 721 mg/kg. The toxic effect of C60 fullerene was observed at a concentration of 300 mg/kg and higher, it was accompanied with mice behavior disturbance, hematotoxicity and pathomorphological changes in spleen, hepatic and kidney tissues. In mice treated with 600 mg/kg of C60 fullerene indices of inflammatory process were detected, whereas at 1200 mg/kg dose leukopoies and thrombocytopoies were found to be suppressed. Thus, C60 fullerene aqueous colloid solution in a dose range of 75-150 mg/kg is nontoxic and could be used for biomedical purposes.

21 March 2023 in Food Research International
Verified
Journal Article
Closed access
MHMarcos Herkenhoff
Marcos Herkenhoff
Carolina BattistiniCarolina Battistini
Carolina Battistini
APAna Beatriz Praia
Ana Beatriz Praia
BRBruno C. Rossini
Bruno C. Rossini
Lucilene Delazari dos SantosLucilene Delazari dos Santos
Lucilene Delazari dos Santos
SSSusana Marta Isay Saad
Susana Marta Isay Saad

21 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
UTUlrich M. Tillich
Ulrich M. Tillich
SLSandra Lehmann
Sandra Lehmann
KSKatja Schulze
Katja Schulze
UDUlf Dühring
Ulf Dühring
MFMarcus Frohme
Marcus Frohme
Random mutagenesis is a useful tool to genetically modify organisms for various purposes, such as adaptation to cultivation conditions, the induction of tolerances, or increased yield of valuable substances. This is especially attractive for systems where it is not obvious which genes require modifications. Random mutagenesis has been extensively used to modify crop plants, but even with the renewed interest in microalgae and cyanobacteria for biofuel applications, there is relatively limited current research available on the application of random mutagenesis for these organisms, especially for cyanobacteria. In the presented work we characterized the lethality and rate of non-lethal point mutations for ultraviolet radiation and methyl methanesulphonate on the model cyanobacteria Synechocystis sp. PCC6803. Based on these results an optimal dosage of 10–50 J/m2 for UV and either 0.1 or 1 v% for MMS was determined. A Synechocystis wildtype culture was then mutagenized and selected for increased temperature tolerance in vivo. During the second round of mutagenesis the viability of the culture was monitored on a cell by cell level from the treatment of the cells up to the growth at an increased temperature. After four distinct rounds of treatment (two with each mutagen) the temperature tolerance of the strain was effectively raised by about 2°C. Coupled with an appropriate in vivo screening, the described methods should be applicable to induce a variety of desirable characteristics in various strains. Coupling random mutagenesis with high-throughput screening methods would additionally allow to select for important characteristics for biofuel production, which do not yield a higher fitness and can not be selected for in vivo, such as fatty acid concentration. In a combined approach with full genome sequencing random mutagenesis could be used to determine suitable target-genes for more focused methods.